For the integrated multidisciplinary approach to patient care

Return to the Southern Medical Journal

Current User S2 Access Level: -1 ()
CAN NOT ACCESS LEVEL 2

The Rising Tide: Skin and Soft Tissue Infections Due to Community-Associated Methicillin-Resistant Staphylococcus aureus

Michael P. Stevens MD, Michael B. Edmond MD, MPH, MPA
Volume: 102 Issue: 2 February, 2009

Abstract:

Article:

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

Images:

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

References:

References1. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436–1444.FridkinSK]]HagemanJC]]MorrisonM&etal;Methicillin-resistant Staphylococcus aureus disease in three communities.N Engl J Med20053521436-14442. Gorwitz RJ. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2008;27:1–7.GorwitzRJA review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.Pediatr Infect Dis J2008271-73. Deurenberg RH, Vink C, Kalenic S, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007;13:222–235.DeurenbergRH]]VinkC]]KalenicS&etal;The molecular evolution of methicillin-resistant Staphylococcus aureus.Clin Microbiol Infect200713222-2354. Le J, Lieberman JM. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy 2006;26:1758–1770.LeJ]]LiebermanJMManagement of community-associated methicillin-resistant Staphylococcus aureus infections in children.Pharmacotherapy2006261758-17705. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–674.MoranGJ]]KrishnadasanA]]GorwitzRJ&etal;Methicillin-resistant S. aureus infections among patients in the emergency department.N Engl J Med2006355666-6746. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785–1791.KaplanSL]]HultenKG]]GonzalezBE&etal;Three-year surveillance of community-acquired Staphylococcus aureus infections in children.Clin Infect Dis2005401785-17917. Furuya EY, Cook HA, Lee MH, et al. Community-associated methicillin-resistant Staphlococcus aureus prevalence: how common is it? A methodological comparison of prevalence ascertainment. Am J Infect Control 2007;35:359–366.FuruyaEY]]CookHA]]LeeMH&etal;Community-associated methicillin-resistant Staphlococcus aureus prevalence: how common is it? A methodological comparison of prevalence ascertainment.Am J Infect Control200735359-3668. Tejeda-Ramirez E, Behani M, Leggiadro RJ. Community-associated methicillin-resistant staphylococcal infection in an inner city hospital pediatric inpatient population. South Med J 2009;102:135–138.Tejeda-RamirezE]]BehaniM]]LeggiadroRJCommunity-associated methicillin-resistant staphylococcal infection in an inner city hospital pediatric inpatient population.South Med J2009102135-1389. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044–4048.RajendranPM]]YoungD]]MaurerT&etal;Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.Antimicrob Agents Chemother2007514044-4048

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

Permissions